Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

News | Heart Failure

February 12, 2020 — The U.S. Food and Drug Administration (FDA) has approved Carmat's investigational device exemption ...

Home February 12, 2020
Home
News | Angiography

February 12, 2020 — The University of Wisconsin (UW) Health’s University Hospital in Madison, Wis., recently became the ...

Home February 12, 2020
Home
Videos | Heart Failure

Interview with James Udelson, M.D., chief of the division of cardiology at Tufts Medical Center, Boston. The hospital ...

Home February 10, 2020
Home
News | Hypertension

February 7, 2020 — The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the Aria ...

Home February 07, 2020
Home
News | Interventional Radiology

February 4, 2020 — For some patients, kidney cancer can be effectively treated without surgery, according to the Society ...

Home February 04, 2020
Home
News | Left Atrial Appendage (LAA) Occluders

February 3, 2020 — The U.S. Food and Drug Administration (FDA) has approved a the CATALYST trial designed to assess ...

Home February 03, 2020
Home
News | Dave Fornell, Editor

February 3, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) m ...

Home February 03, 2020
Home
News | Heart Valve Technology

January 31, 2020 — A new study from the Smidt Heart Institute at Cedars-Sinai and other centers nationwide shows that ...

Home January 31, 2020
Home
News | Endovascular Aortic Repair

January 31, 2020 – The Society for Vascular Surgery (SVS) and Society of Thoracic Surgeons (STS) released new reporting ...

Home January 31, 2020
Home
Abbott Tendyne TMVR, TMVI system received European CE mark clearance in January 2020. The Abbott Tendyne transcatheter mitral valve replacement (TMVR) system uses an anchor attached to the apex of the heart with a whether line attached to the valve. This helps to keep the valve anchored in the mitral annulus and prevent embolization. This anchor system was used because, unlike the aortic valve, the mitral valve has a very thin landing zone to secure the valve. Prevents LVOT obstruction.
Feature | Heart Valve Technology

January 30, 2020 — The Abbott Tendyne Transcatheter Mitral Valve Implantation (TMVI) system received European CE mark ...

Home January 30, 2020
Home
News | Endovascular Aortic Repair

January 29, 2020 – The presence of a blood clot on the wall of the aorta in people with abdominal aortic aneurysms (AAA) ...

Home January 29, 2020
Home
Videos | Heart Valve Technology

Interview with Andrew Weintraub, M.D., FACC, associate director, of the Interventional Cardiology and Vascular Center ...

Home January 28, 2020
Home
Subscribe Now